Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.

Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.

<h4>Background</h4>The optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patients with end-stage renal disea...

Full description

Bibliographic Details
Main Authors: Yi-Cheng Lin, Bi-Li Chen, Chun-Ming Shih, Feng-Yen Lin, Chih-Wei Chen, Chien-Yi Hsu, Yung-Ta Kao, Wei-Fung Bi, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang, Chun-Yao Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0249940

Internet

https://doi.org/10.1371/journal.pone.0249940

Similar Items